What are the components and operating principles of a linear accelerator (LINAC) used for external‑beam radiotherapy as described in the standard Khan textbook?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Linear Accelerator (LINAC) Components and Operating Principles

Core Technology and Definition

A linear accelerator (LINAC) is a microwave-powered electron accelerator that has become the dominant radiotherapy treatment unit, using radiofrequency energy to accelerate electrons through an accelerating structure (waveguide) to produce high-energy photon or electron beams for external beam radiotherapy. 1

Major Components

1. Radiofrequency (RF) Power Source

  • Magnetron or klystron generates microwave power, typically operating at S-band frequency (approximately 3 GHz) in conventional systems 1, 2
  • Newer compact systems utilize X-band technology (9.3 GHz), allowing for miniaturization while maintaining therapeutic beam quality 2
  • The RF source provides the electromagnetic energy needed to accelerate electrons through the waveguide 1

2. Electron Gun

  • Produces the initial electron beam through thermionic emission 2
  • Operates in a constant emission region to maintain stable beam current 2
  • Typical beam currents exceed 90 mA in modern systems 2

3. Accelerating Structure (Waveguide)

  • Side-coupled or standing-wave structures are used to efficiently accelerate electrons while reducing RF power loss 2
  • Modern X-band systems achieve therapeutic energies with accelerating tubes as short as 37 cm, compared to longer S-band structures 2
  • High shunt impedance and electric field strength enable acceleration to >6 MeV even in compact designs 2

4. Beam Transport System

  • Bending magnets guide the accelerated electron beam from the accelerating structure to the treatment head 1
  • Focusing magnets maintain beam collimation and prevent divergence 1

5. Treatment Head Components

Primary Collimator

  • First-stage beam shaping device 3
  • Removing this component increases both photon and neutron fluences at isocenter 3

Target (for Photon Mode)

  • High-Z material (typically tungsten) where electrons strike to produce bremsstrahlung X-rays 3
  • Generates the therapeutic photon beam through electron-photon conversion 4

Flattening Filter

  • Creates a uniform dose distribution across the treatment field 3
  • Modern flattening filter-free (FFF) beams are increasingly used for stereotactic treatments, resulting in higher dose rates but different beam characteristics 2
  • Removal increases both neutron contamination and photon fluence 3

Secondary Collimator (Jaws)

  • Provides rectangular field shaping 3
  • Works in conjunction with the MLC for field definition 2

Multi-Leaf Collimator (MLC)

  • Enables complex field shapes for conformal and intensity-modulated radiotherapy 3
  • Contributes to neutron production at energies >10 MV 3

Operating Principles

Energy Production and Beam Characteristics

  • Clinical LINACs typically operate at 6,10,15,18, and 24 MV photon energies 3
  • Widely variable energy linacs allow selection of different energies for optimal treatment 1
  • Electron beams (when available) range from 4-20 MeV for superficial treatments 5
  • Modern systems achieve dose rates of 820 cGy/min or higher at standard distances 2

Beam Quality and Spectrum

  • The photon energy spectrum is complex and influenced by all treatment head components 3, 4
  • Percent depth dose (PDD) ratios at 10 cm and 20 cm depth characterize beam energy (e.g., PDD₁₀/PDD₂₀ ≈ 0.572 corresponds to 6 MV) 2
  • Beam quality can be verified through transmission measurements using graphite and lead attenuators 4

Neutron Contamination

  • Photonuclear reactions produce neutron contamination at energies >10 MeV 3
  • All treatment head components contribute to neutron production, with removal of any component increasing neutron fluence 3
  • Requires additional shielding considerations compared to lower-energy systems 5

Clinical Implementation Standards

Treatment Planning and Delivery

  • 3D CT-based treatment planning with dose-volume histograms enables precise targeting 6
  • Intensity-modulated radiation therapy (IMRT) uses multileaf collimators for complex dose distributions 6
  • Image-guided radiotherapy (IGRT) with fiducial markers or ultrasound improves accuracy 6

Dose Delivery Requirements

  • For lung cancer, minimum 60 Gy with classical fractionation is standard for curative intent 6
  • Dose escalation to 75-79 Gy has been safely achieved with 3D conformal techniques for prostate cancer 6
  • Stereotactic body radiation therapy (SBRT) delivers high doses in 5 or fewer fractions using LINAC-based systems 6

Quality Assurance

  • Beam parameters (energy, dose rate, flatness, symmetry, penumbra) must meet AAPM TG-51, TG-106, TG-142, and IAEA TRS-398 protocols 2
  • Flatness and symmetry specifications ensure uniform dose delivery 2
  • Periodic verification of beam quality through transmission measurements maintains dosimetric accuracy 4

Comparison with Alternative Technologies

LINAC vs. Cobalt-60

  • LINACs offer higher beam energy, modulated dose rate, and smaller focal spot size for optimized conformal treatments 5
  • Infrastructure and maintenance are more demanding for LINACs due to complex electrical components 5
  • Life cycle costs are higher for LINACs, especially multi-energy systems 5
  • LINACs enable more complex treatment techniques including IMRT and SBRT 5

Stereotactic Radiosurgery Applications

  • LINAC-based stereotactic systems deliver radiosurgery by moving the gantry to change beam delivery angles 7
  • For tumors >3 cm diameter, hypofractionated stereotactic radiotherapy using LINAC systems is generally preferred over single-fraction Gamma Knife 7
  • CyberKnife systems (LINAC-mounted on robotic arms) achieve submillimeter accuracy without stereotactic frames 7
  • No platform has demonstrated superiority; success depends on correct application by treating physicians 7

Advanced Applications

Emerging Technologies

  • FLASH radiotherapy using modified LINACs achieves ultra-high dose rates >160-200 Gy/s, potentially reducing normal tissue toxicity while maintaining tumor control 8
  • X-band compact LINACs enable integration with MRI or CT imaging systems in limited spaces 2
  • Tracking systems with robotic arms allow energy delivery from any location around the patient 6

Critical Safety Considerations

Radiation Protection

  • Concrete bunker shielding requirements are substantial, with additional neutron shielding needed for high-energy (>10 MV) LINACs 5
  • Staff training requirements are more extensive for LINACs compared to simpler technologies 5

Heart-Sparing Techniques

  • Deep inspiration breath-hold or respiratory gating shields the heart during left breast irradiation 6
  • Multiple or rotational beam arrangements minimize cardiac dose 6
  • Modern planning systems with dose-volume histograms enable precise cardiac dose limitation 6

References

Research

Effect of each component of a LINAC therapy head on neutron and photon spectra.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2018

Research

Cobalt-60 Machines and Medical Linear Accelerators: Competing Technologies for External Beam Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gamma Knife Surgery for Intracranial Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

FLASH Radiation Therapy with Linear Accelerators

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is a linear accelerator (LINAC) and how is it used in external‑beam radiation therapy?
Should we shift from cobalt (Cobalt-60) to linac (Linear Accelerator) for radiation therapy?
In a 50‑year‑old woman on combined HRT with transdermal estradiol patch (Estradot 25 µg/24 h) and oral micronized progesterone (Utrogestan 100 mg daily) who still has brain fog and insomnia, no vaginal bleeding, and requests an earlier refill, should the estradiol dose be increased to a higher‑strength patch rather than refilling the same dose?
In a patient with atrial fibrillation who already has a pacemaker, should oral anticoagulation still be prescribed based on the CHA₂DS₂‑VASc score?
In an HIV‑positive neutropenic patient with bandemia, elevated procalcitonin and elevated lactate who shows circumferential thickening of the ascending colon and hepatic flexure on imaging, what are the most likely diagnoses and how should they be managed emergently?
In a 65‑year‑old bipolar patient with chronic kidney disease, does discontinuation of lithium lead to hypoalbuminemia?
Can letrozole be combined with fulvestrant in estrogen‑receptor‑positive breast cancer?
How do I order bioidentical testosterone for an adult male with documented low testosterone and symptoms (decreased libido, fatigue, loss of muscle mass, mood changes) after confirming no contraindications (active prostate or breast cancer, prostate‑specific antigen >4 ng/mL without urologic evaluation, untreated severe sleep apnea, uncontrolled hypertension, hematocrit >50%)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.